EP1185286A4 - MU O-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHESICS - Google Patents

MU O-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHESICS

Info

Publication number
EP1185286A4
EP1185286A4 EP00939692A EP00939692A EP1185286A4 EP 1185286 A4 EP1185286 A4 EP 1185286A4 EP 00939692 A EP00939692 A EP 00939692A EP 00939692 A EP00939692 A EP 00939692A EP 1185286 A4 EP1185286 A4 EP 1185286A4
Authority
EP
European Patent Office
Prior art keywords
conopeptide
local anesthetic
anesthetic
local
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00939692A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1185286A1 (en
Inventor
Baldomero M Olivera
J Michael Mcintosh
R Tyler Mccabe
James E Garrett
Richard T Layer
John D Wagstaff
Robert M Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognetix Inc
University of Utah Research Foundation Inc
Original Assignee
Cognetix Inc
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognetix Inc, University of Utah Research Foundation Inc filed Critical Cognetix Inc
Publication of EP1185286A1 publication Critical patent/EP1185286A1/en
Publication of EP1185286A4 publication Critical patent/EP1185286A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP00939692A 1999-06-10 2000-06-09 MU O-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHESICS Withdrawn EP1185286A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13850799P 1999-06-10 1999-06-10
US138507P 1999-06-10
PCT/US2000/015779 WO2000076532A1 (en) 1999-06-10 2000-06-09 νO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS

Publications (2)

Publication Number Publication Date
EP1185286A1 EP1185286A1 (en) 2002-03-13
EP1185286A4 true EP1185286A4 (en) 2004-09-08

Family

ID=22482336

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00939692A Withdrawn EP1185286A4 (en) 1999-06-10 2000-06-09 MU O-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHESICS

Country Status (5)

Country Link
EP (1) EP1185286A4 (enExample)
JP (1) JP2003501109A (enExample)
AU (1) AU5474200A (enExample)
CA (1) CA2376357A1 (enExample)
WO (1) WO2000076532A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2740401A (en) 1999-12-30 2001-07-16 Cognetix, Inc. O-superfamily conotoxin peptides
GB0011202D0 (en) * 2000-05-09 2000-06-28 Kci Licensing Inc Abdominal wound dressing
WO2002007756A1 (en) * 2000-07-20 2002-01-31 Cognetix, Inc. MuO-CONOPEPTIDES AND THEIR USE AS LOCAL ANESTHETICS
JP2004537253A (ja) * 2000-07-21 2004-12-16 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション ミュー−コノペプチド
DK2051991T3 (da) * 2006-08-17 2012-01-30 Eribis Pharmaceuticals Ab Cardiobeskyttende forbindelser

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719264A (en) * 1994-10-07 1998-02-17 Univ. Of Utah Research Foundation Conotoxin peptides
FR2785613A1 (fr) * 1998-11-10 2000-05-12 Commissariat Energie Atomique Conotoxine isolee a partir du venin de conus ermineus, ses analogues et ses applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216751A1 (en) * 1995-04-17 1996-10-24 Doju Yoshikami Conotoxin peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719264A (en) * 1994-10-07 1998-02-17 Univ. Of Utah Research Foundation Conotoxin peptides
FR2785613A1 (fr) * 1998-11-10 2000-05-12 Commissariat Energie Atomique Conotoxine isolee a partir du venin de conus ermineus, ses analogues et ses applications

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAI-SONG L ET AL: "CONOPEPTIDES FROM CONUS STRIATUS AND CONUS TEXTILE BY CDNA CLONING", PEPTIDES, ELMSFORD, US, vol. 20, 1999, pages 1139 - 1144, XP002939062, ISSN: 0196-9781 *
FAINZILBER M ET AL: "NEW SODIUM CHANNEL-BLOCKING CONOTOXINS ALSO AFFECT CALCIUM CURRENTSIN LYMNAEA NEURONS", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 34, no. 16, 25 April 1995 (1995-04-25), pages 5364 - 5371, XP002061899, ISSN: 0006-2960 *
See also references of WO0076532A1 *
TERLAU HEINRICH ET AL: "Mu-O-conotoxin MrVIA inhibits mammalian sodium channels, but not through site I", JOURNAL OF NEUROPHYSIOLOGY (BETHESDA), vol. 76, no. 3, 1996, pages 1423 - 1429, XP009034053, ISSN: 0022-3077 *

Also Published As

Publication number Publication date
WO2000076532A1 (en) 2000-12-21
AU5474200A (en) 2001-01-02
EP1185286A1 (en) 2002-03-13
JP2003501109A (ja) 2003-01-14
CA2376357A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
DE59803292D1 (de) Triazolverbindungen und deren verwendung als dopamin-d 3-liganden
DE60001840D1 (de) Chinuclidin-derivate und deren verwendung als muscarin-m3-rezeptoren-liganden
DE60045321D1 (de) Mutilinderivate und deren Verwendung als antimikrobielle Agenzien
DE60016611D1 (de) Chinolinpropyl-piperidinderivate und deren verwendung als antibakterielle wirkstoffe
DE60027479D1 (de) Harzstruktur und ihre verwendung
DE50111690D1 (de) 2-acyl-indolderivate und deren verwendung als antitumormittel
DE60113719D1 (de) Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
ATE298337T1 (de) Neue verwendung sowie neue n-azabicycloamid- verbindungen
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
PT1204663E (pt) Novos compostos espiro com actividade antagonista do neuropeptido y
DE69911378D1 (de) Fluorierte ionomere und verwendung davon
DE60105859D1 (de) Urazil Verbindungen und deren Verwendung
ATE273301T1 (de) Substituierte aza- und diazacycloheptan- und - cyclooctanverbindungen und deren verwendung
ATE260033T1 (de) Biozide zusammensetzung und deren verwendung
DE60104776D1 (de) Diphenylharnstoffderivate und deren Verwendung als alpha2/5-HT2c Antagonisten
DE60027927D1 (de) Harzstruktur und ihre verwendung
DE60114413D1 (de) Substituierte 1-aminoalkyl-lactame und deren verwendung als muscarinrezeptor-antagonisten
ATE364575T1 (de) Zeolithe und deren verwendung
DE60021507D1 (de) Uracilverbindungen und deren Verwendung
DE50011452D1 (de) Polyalkenalkohol-polyalkoxylate und deren verwendung in kraft- und schmierstoffen
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
ATE215061T1 (de) ((3-alkoxy-phenoxy)-ethyl)-dialkylaminderivate und deren verwendung als lokalanaesthetika
ATE250339T1 (de) Dormanz-brechende zusammenstezung und deren verwendung
DE60013191D1 (de) Tensidzusammensetzung und deren Verwendung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040728

17Q First examination report despatched

Effective date: 20050704

17Q First examination report despatched

Effective date: 20050704

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070201